Navigation Links
Abbott Launches Next-Generation XIENCE PRIME(TM) Drug Eluting Stent in International Markets
Date:8/31/2009

BARCELONA, Spain, Aug. 31 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) today announced at the European Society of Cardiology Congress the widespread availability of its next-generation XIENCE PRIME(TM) Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease. XIENCE PRIME, which received CE Mark (Conformite Europeenne) in June, offers a novel stent design and a delivery system designed for greater flexibility and enhanced deliverability. XIENCE PRIME is now widely available in Europe and in select countries throughout Asia-Pacific and Latin America.

"Abbott's XIENCE PRIME is an improvement in design, deliverability and conformability, all of which can be distinctly observed during coronary stent procedures, in both everyday and complex lesions," said Antonio Bartorelli, M.D., director of the Interventional Cardiology Department of the Centro Cardiologico Monzino, University of Milan, Italy. "XIENCE PRIME is designed to be easily deliverable even in complex cases and very long lesions."

XIENCE PRIME utilizes the same well-studied drug and proven biocompatible polymer as Abbott's market-leading XIENCE V(R) Everolimus Eluting Coronary Stent System. XIENCE PRIME is based upon the well-tested design used in the MULTI-LINK VISION(R) family of stents, which is the most widely used stent platform in the world - more than 2 million of Abbott's cobalt chromium stents have been implanted worldwide.

"XIENCE PRIME leverages the superior outcomes from the extensive body of clinical evidence from the SPIRIT family of clinical trials, and offers design and delivery system properties that make it even easier for a physician to appropriately reach and treat a lesion," said Patrick Serruys, M.D., Ph.D., professor of interventiona
'/>"/>

SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Abbott to Collaborate With Pfizer Inc on Companion Diagnostic Test to Select Patient Candidates for Novel Investigational Non-Small Cell Lung Cancer Therapy
2. Health Canada Approves Abbotts XIENCE V(R) Drug Eluting Stent
3. Abbott Testifies Before U.S. Congress on Role of Private Sector in Advancing Science Education
4. Abbott to Acquire Nutrition Businesses, Expanding Presence in India
5. Abbott and Medtronic Reach Agreement on Global Patent Disputes
6. NeoGenomics Enters into Strategic Supply Agreement with Abbott for Development of a Melanoma Cancer Test
7. Abbott Introduces Molecular Diagnostic System Intended for Broad Identification of Infectious Agents
8. Abbott Launches New Instrument to Complete Family of ARCHITECT Immunochemistry Analyzers
9. Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009
10. Abbott and Oasmia Pharmaceutical Announce Exclusive Distribution Agreement for Paccal(R) Vet, a New Chemotherapeutic Agent for Dogs
11. Abbott Hosts Conference Call for Second-Quarter Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... Engineering and Physical Sciences Research Council (EPSRC) will ... industrial control systems which run, for example, manufacturing ... rail network. , The research will help ... infiltrating the systems behind our critical national infrastructure. ... Control Systems (RITICS), based at Imperial College London, ...
(Date:10/1/2014)... (October 1, 2014) Despite a policy focus ... developmental disabilities, this vulnerable population continues to have ... The Journal of the American Dental Association ... and Tufts University School of Dental Medicine report ... influencing at-home oral care provided by caregivers to ...
(Date:10/1/2014)... Familylifeinsurancequotes.org has released a new blog post ... , Senior citizens can qualify for affordable term ... seniors who are over 50 years old. Some term ... medical examination. , Term life insurance with a simplified ... qualify. Having life insurance during retirement is important for ...
(Date:10/1/2014)... 01, 2014 Insuranceragents.info has released ... good life insurance plan for vulnerable family members. , ... family members. Providers in the family should always carry ... financial hardships for the rest of the family. ... Families can benefit more from temporary coverage or from ...
(Date:10/1/2014)... 2014 Lifeinsurance-policy.com has released a ... life insurance prices for smokers. , Smoking will always ... Comparing quotes is the best method to find affordable ... customers who need coverage. , Whole life insurance ... the policy. Since the coverage is permanent, the initial ...
Breaking Medicine News(10 mins):Health News:£2.5 million to recognize and reduce cyber-attack threats to critical infrastructure 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 3Health News:Affordable Term Life Insurance - Senior Citizens Can Qualify for Coverage! 2Health News:Life Insurance for Families - Clients Can Compare Affordable Rates Online! 2Health News:Affordable Whole Life Insurance Premiums for Smokers! 2
... person,s gene profile seems to dictate reponse, study finds , , ... seems to influence how he or she reacts to certain ... genes with medications may help save a patient,s life, experts ... observation. It,s a large study with hard clinical endpoints," said ...
... to American Heart Month, which is just ahead in ... Control and Prevention (CDC) shows that, since 1999, coronary ... by 25.8 percent and 24.4 percent, respectively. This ... for reducing deaths from coronary heart disease has been ...
... UCLA study shows that only about half of children ... cognitive defects commonly associated with the condition. ... where medication is rarely prescribed to treat ADHD, the ... to populations in which medication is widely used. ...
... Marcy Leger Joins Agency as Executive Vice President, Managing ... Life, a leading healthcare,communications network, announced that Marcy Leger ... of Euro RSCG Life LM&P New,York, as a result ... to David Paragamian, Partner, President of Euro RSCG Life ...
... 22 NASA will release a,report on an ... and,hold a media teleconference to discuss the report ... NASA requested an independent external committee,conduct a comprehensive ... same time, NASA,s Johnson Space Center, Houston, began ...
... Children of Alcoholics Offer ... on January 30, 2008, CLEVELAND, Jan. 22 ... the National Association of Children,of Alcoholics (NACOA) have partnered ... a free one-day training program. The seminar will,help participants ...
Cached Medicine News:Health News:Genetics Influence Blood Pressure Medications 2Health News:Genetics Influence Blood Pressure Medications 3Health News:Heart and stroke death rates steadily decline; risks still too high 2Health News:Heart and stroke death rates steadily decline; risks still too high 3Health News:Heart and stroke death rates steadily decline; risks still too high 4Health News:Study raises questions about diagnosis, medical treatment of ADHD 2Health News:Study raises questions about diagnosis, medical treatment of ADHD 3Health News:Euro RSCG Life LM&P Announces Growth of Leadership Team 2
(Date:10/1/2014)... SAN MARCOS, Texas , Oct. 1, 2014 ... that it is scaling volume production of photoactive ... solar power technologies . While offering numerous advantages ... difficulty of producing large quantities of quantum dots ... has until now kept them from commercial utilization ...
(Date:10/1/2014)... 1, 2014 Ardelyx, Inc. (NASDAQ: ... company focused on cardio-renal, gastrointestinal and metabolic ... 371 patient Phase 2b clinical trial evaluating ... syndrome (IBS-C).  Results from this study demonstrated ... IBS-C symptoms for tenapanor-treated patients compared to ...
(Date:10/1/2014)... , Switzerland , October 1, ... leader in Clinical Genomics and Next Generation Sequencing (NGS) ... allowing clinicians to run full cystic fibrosis analysis in ... the identification and characterisation of all types of variants ... performance. Until now, it has not been ...
Breaking Medicine Technology:Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 2Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 3Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 2Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 3Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 4Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 5Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 6Sophia Genetics Launches Full CFTR Analysis in Single Clinical Grade NGS Experiment 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: